Joseph Italiano: Exploring the Intersection of Megakaryocyte Biology and Chronic Kidney Disease
Joseph Italiano, Associate Professor of Medicine of Harvard University and Co-founder of Platelet BioGenesis, shared a post on LinkedIn about recent article he and his colleagues co-authored:
“I’m excited to share our latest study, published in Blood Advances and led by Estelle Carminita, exploring the intersection of megakaryocyte biology and chronic kidney disease.
In this work, we demonstrate that chronic kidney disease reprograms megakaryocytes, driving the production of dysfunctional platelets.
We’re deeply grateful to our outstanding collaborators whose expertise and dedication made this work possible.”
Title: Platelet dysfunction in chronic kidney disease arises from bone marrow remodeling and megakaryocyte reprogramming
Authors: Estelle Carminita, Virginia Camacho, Siobhan Branfield, Ethan Walsey, Maria N. Barrachina, Dylan N. Tabang, Dong H. Lee, Isabelle C. Becker, Sergey V. Brodsky, Samer M. Issa, Nicolas Gendron, Sarah Machado, Alisa S. Wolberg, Hanno Steen, Bryce Kerlin, Kellie R. Machlus, Abolfazl Zarjou, Joseph E. Italiano
Read the Full Article on Blood Advances.
Stay updated with Hemostasis Today.
-
Apr 17, 2026, 08:32Leslie Johns: Our First Low Titer O Whole Blood Products
-
Apr 17, 2026, 08:24Dominique P. Germain: The Critical Role of Cardiac Involvement in Fabry Disease
-
Apr 17, 2026, 07:54Pat Garcia-Gonzalez: Does Having Lifesaving Medicine at a Hospital Guarantee Patient Access?
-
Apr 17, 2026, 05:41Tareq Abadl: Sickle Cell Anemia is Not Just Hemoglobin Deficiency, It’s a Genetic Mutation
-
Apr 17, 2026, 04:58Emmanuel J Favaloro: A Century of von Willebrand Disease – From Discovery to Modern Diagnostic Pathways
-
Apr 17, 2026, 02:41Helena Bradbury: First Haematology EAHAD Supplement of 2026
-
Apr 16, 2026, 18:27Are We Underestimating VTE After PanNET Surgery? – RPTH Journal
-
Apr 16, 2026, 16:10Hamid Noori: Understanding the Cause of Anemia through Etiological Classification
-
Apr 16, 2026, 15:29Sebastian Klapa: Key Findings On Mortality And Cardiovascular Risk In ANCA-Associated Vasculitis